Investment and money
Apple's China syndrome

Aggressive growth stock pick: HSN

Don't fight the 'fiscal slice'

Top picks 2013: Susser Petroleum

B of A inks whopping $10 billion mortgage settlement

Wendy's hikes prices: Here come falling sales

7 hot tech stocks to watch in 2013

Investing in breakfast stocks

Precious opportunities for traders

Google starts the year with a big win

Discover launches new no-fee credit card

Statoil expands its global reach

Top picks 2013: Oakmark Int'l, Matthews Asian

Top picks 2013: Gladstone Commercial

Inside Wall Street: CVS for your 2013 portfolio

Peregrine Pharma soars 80% on study review

Network stocks: 2 buys, 2 sells

Research In Motion is still doomed

Target targets showrooming shoppers

Top picks 2013: Triumph

Will big bank stocks keep up their big run in 2013?

Alcoa is shining brighter

Can HBO compete with Netflix?

Credit Suisse says Bank of America overvalued

Retailers face spending slowdown

Top picks 2013: Oakmark Int'l, Matthews Asian
Foreign markets were out of favor for the past two years, but came roaring back in the third quarter of 2012.

One of the top performing diversified international funds to come up our ranks was Oakmark International (OAKIX +0.78%), our top aggressive pick. For conservative investors, Matthews Asian Growth & Income (MACSX -0.16%) is a relatively low volatility way to access to this leading area of the market.

Oakmark International
Among international markets, Europe was one of the strongest-performingr03; regions and OAKIX is primarily invested in developed European companies (67%).

The remainder of the portfolio is invested in stocks from Japan, Australia and Canada. The fund has virtually no exposure to emerging markets -- 0.2% in Mexico.

OAKIX invests primarily in large-cap international companies that the fund's managers believe have strong growth prospects but are undervalued. Financial stocks, which lagged in 2011, make up 29% of the fund's portfolio.

To protect against currency risks, OAKIX's managers have hedged some of the fund's currency exposure. OAKIX is up 22.4% year-to-date through December 15, 2012.

Matthews Asian Growth & Income
Matthews Asian Growth & Income is one of the few Asia funds with market-level risk because it's not solely invested in emerging Asian markets.

Instead, MACSX is widely diversified: it has 69% of its portfolio invested in developed Asian markets like Singapore and Hong Kong, and the remaining 31% is invested in emerging economies like China and India, which have strong growth prospects.

MACSX also may invest in countries outside Asia, such as Australia and the United Kingdom.

Another way MACSX attempts to manage risk is by holding both dividend-paying stocks and convertible bonds. Both contribute to the fund's yield, which was 1.91% as of September 30, 2012. MACSX is up 24.8% year-to-date through December 15, 2012. MACSX has a redemption fee on shares held less than 90 days.

Для печати
MGM gets nod for second casino in Macau

Facebook's announcement no big deal

Market trends show stunning flip-flops

An aggressive bet on pollution control

Hewlett-Packard: The Dow's top underdog

Buffett should reconsider Goldman Sachs

Apple gets price target, estimate cut

Less is still more for US restaurant chains

Boeing hopes to fly above 787 safety storm

Can Dell save itself by going private?

We could be in for a year of M&A

Play the housing rebound with this stock

The best commodity play: Plain Jane ETFs

Earnings season off to a superb start

Herbalife: Battle of the hedge funds

Ford doubles dividend - is it now an income stock?

Face time with Mark Zuckerberg?

Whole Foods should buy Trader Joe's

Is fee pressure latest threat to 'old' network TV model?

Why Wal-Mart could be an $80 stock

Uncertainty looms large as earnings season starts

Boeing shares slip as FAA review of 787 begins

Is Bill Ackman's Pershing Square toast?

4 stocks shining in the Oscar spotlight

Volcano, St. Jude: 2 hearts beat as one

Bowling, billiards, boating make Brunswick a buy

MGM sees progress on Macau casino

Glaxo to enter packed field of diabetes drugs

The new Corvette Stingray: Worth the wait?

It's time to eat some crow

Johnson Controls to benefit from start-stop batteries

Citi Trends upgraded to 'outperform'

When Apple falls, these 3 fall with it

Can Michael Dell save his struggling PC empire?

Car dealer stocks: Kick the tires carefully

Investors welcome China's market moves

Inside Wall Street: Noble expands offshore drilling

Is Hewlett-Packard stock a bargain or a landmine?